ASA Webinar Series
|
Acoustical Sciences • Applications of Acoustics • Careers in Acoustics |
Michael Gray is Senior Researcher in Clinical Therapeutic Ultrasound at the University of Oxford Institute of Biomedical Engineering, Oxford, UK. He holds a PhD from the Georgia Institute of Technology in Mechanical Engineering. His research focuses on three areas: early phase clinical trials of ultrasound-mediated drug delivery for treatment of abdominal organ cancers, clinical translation of quantitative cavitation monitoring techniques for non-invasive treatment guidance, and development of devices to enable the use of sound, magnetism, and light for targeted drug delivery.
Dr. Gray joined Oxford’s biomedical ultrasonics, biotherapy and biopharmaceuticals laboratory (BUBBL) in 2015 as the lead engineer on a Phase-1 clinical trial of ultrasound-mediated targeted drug delivery for treatment of liver cancer. Over the preceding 23 years, he was a research engineer and principal investigator at Georgia Tech, working in areas including sonar, cetacean soft tissue characterization, photoacoustics, fish hearing, and non-destructive structural evaluation. He is a member of the Acoustical Society of America, the American Institute of Ultrasound in Medicine, and the International Society for Therapeutic Ultrasound, and he is currently serving on the Cavitation Standard Project Team – a joint committee of FUSF/IEC that is developing a standard for measurement techniques to detect and monitor cavitation.